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Abstract: Grb7 and their related family members Grb10 and Grb14 are adaptor proteins, which participate in the func-
tionality of multiple signal transduction pathways under the control of a variety of activated tyrosine kinase receptors and 
other tyrosine-phosphorylated proteins. They are involved in the modulation of important cellular and organismal func-
tions such as cell migration, cell proliferation, apoptosis, gene expression, protein degradation, protein phosphorylation, 
angiogenesis, embryonic development and metabolic control. In this short review we shall describe the organization of the 
genes encoding the Grb7 protein family, their transcriptional products and the regulatory mechanisms implicated in the 
control of their expression. Finally, the alterations found in these genes and the mechanisms affecting their expression un-
der pathological conditions such as cancer, diabetes and some congenital disorders will be highlighted. 
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INTRODUCTION 
  The so-called adaptors form an ample group of proteins 
that generally lack enzymatic activity, but play an important 
role in multiple signal transduction processes in the cell. 
They function by bringing together in a proper conforma-
tional manner, different components of given signaling 
pathways to achieve their correct functionality in transmit-
ting signals along defined routes. Among the adaptors found 
in mammalian cells, the growth factor receptor bound pro-
tein 7 (Grb7) family that is formed by three members: Grb7, 
Grb10 and Grb14, has acquired certain relevance. These pro-
teins mediate the interaction between many activated (phos-
phorylated) tyrosine kinase receptors located at the cell sur-
face, from this its acronym Grb pertaining to Growth factor 
receptor bound, and their downstream signaling effector pro-
teins came into existence. In addition, these adaptor proteins 
are able to interact with other non-receptor tyrosine-phos- 
phorylated proteins involved in signaling events (see [1-4] 
for reviews and references therein). 
  The mammalian Grb7 family members show significant 
homology to the Caenorhabditis elegans protein denoted 
Mig10, which is implicated in embryonic neuronal cell mi-
gration [5]. These proteins exhibit a conserved multidomain 
structure. Hence, in their central section they present a region 
termed GM, for Grb and Mig, that includes a Ras-associating 
(RA) domain, which allows for their interaction with mem-
bers of the Ras superfamily of small G proteins; and a pleck-
strin homology (PH) domain whose function is to allow their 
binding to cell membrane phosphoinositides, and where our 
group has additionally identified (in Grb7) a functional   
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calmodulin-binding domain overlapping its proximal region 
[6]. In their N-terminus, these proteins present a proline-rich 
(PR) domain for interaction with proteins containing a Src 
homology 3 (SH3) domain. Distal to the GM region is lo-
cated the BPS domain (for between PH and SH2), which is 
responsible for interaction with the insulin and insulin-like 
growth factor-I (IGF-I) receptors and finally, the C-terminus 
contains the all-important Src homology 2 (SH2) domain, 
whereby the Grb7 family proteins interact with phosphoty-
rosine residues present in activated receptors and signaling 
proteins. The C. elegans Mig10 protein lacks, however, an 
SH2 domain and contains instead an additional PR domain 
in its C-terminus (see [1-4] for reviews and references 
therein). 
  Grb7 interacts with many tyrosine kinase receptors, in-
cluding the epidermal growth factor receptor (EGFR/ErbB1) 
and others, erytoblastic leukemia viral oncogene homolog 
receptors (ErbB2, ErbB3, ErbB4) just to give some examples 
of a set of receptors involved in tumor biology and it has 
been implicated in cellular migration because of its interac-
tion with focal adhesion kinase (FAK) and the erythro-
poietin-producing hepatocellular carcinoma cells receptor B1 
(EphB1), an ephrin receptor. This adaptor protein also plays 
a prominent role in the metastatic spread of tumor cells, 
where it is frequently overexpressed (see [1-4, 7] for reviews 
and references therein). In addition, Grb7 appears to be in-
volved in cellular processes controlling angiogenesis [6], and 
its role in the negative control of protein translation has re-
cently been shown [8]. 
  Grb10 translocates to the plasma membrane upon insulin 
stimulation and binds with high affinity to the insulin recep-
tor, and also with the IGF-I receptor, thereby inhibiting their 
tyrosine kinase activity. Grb10 also acts as a positive regula-
tor of phosphatidylinositol 3-kinase (PI3K)/Akt (for v-akt 
murine thymoma viral oncogene homolog)-mediated cellular  
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functions and it has been shown to associate to the mito-
chondrial outer membrane in response to IGF-I or serum 
treatment, from where it could exert an anti-apoptotic action. 
Grb10 possibly regulates the ubiquitination of target pro-
teins, such as tyrosine kinase receptors, because of its inter-
action with Nedd4, a ubiquitin protein ligase. Furthermore, 
Grb10 seems to play a leading role in development by nega-
tively affecting cell proliferation because of its actions on the 
signaling pathways, which are the insulin and IGF-I recep-
tors, but by the growth hormone receptor as well (see [1-4, 
9-11] for reviews and references therein). Nevertheless, the 
negative control of Grb10 on mitogenesis is not a universal 
event, since a stimulatory role of this protein on cell prolif-
eration mediated by platelet-derived growth factor-BB 
(PDGF-BB), insulin and IGF-I has also been reported [12]. 
  Grb14 exerts its functional roles upon its association with 
the insulin and the fibroblast growth factor receptors, thereby 
inhibiting both cell proliferation and insulin-mediated glyco-
gen synthesis (see [1-4, 13] for reviews and references 
therein). 
  As we have seen, the Grb7 protein family members con-
trol numerous cellular functions because of the variegated 
spectrum of receptors they interact with and the multiplicity 
of receptor-controlled signaling pathways in which these 
adaptor proteins intervene. In order to illustrate the global 
physiological impact of these proteins on the control of cel-
lular functions, Fig. (1) summarizes the main biological pro- 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Control exerted by the Grb7/Grb10/Grb14 proteins on 
cellular and physiological processes. The cartoon represents a 
selected series of cellular and physiologically relevant processes in 
which the Grb7 family member proteins exert a positive or negative 
control by participating in defined signaling pathways. These proc-
esses are: cell migration (Grb7), angiogenesis (Grb7), metabolic 
control (Grb10 and Grb14), development (Grb10), and cell prolif-
eration (Grb10 and Grb14). Encircled plus and minus symbols rep-
resent, respectively, activation and inhibition of the indicated proc-
esses. See text for additional details. 
cesses in which the Grb7/Grb10/Grb14 proteins appear to 
play a relevant role. 
THE GRB7 GENE 
 Human  GRB7 maps to the large arm of chromosome 17 
at the 17q12-q21.1 locus (see Fig. (2) left panel), near to the 
ERBB2 gene within the 17q12 amplicon, which is also called 
the  ERBB2  amplicon [14, 15]. Transgenic mouse models 
expressing activated ErbB2 under the control of its endoge-
nous promoter(s), but not under the control of a mouse 
mammary tumor virus-based promoter, express high levels 
of Grb7 and other genes within the same ERBB2 amplicon, 
such as CAB1 [16]. The major human GRB7 mRNA tran-
script is 2.4 kb long and is accompanied by a less abundant 
transcript of 4.1 kb [15, 17]. The GRB7 gene comprises 15 
exons, of which only 14 have total or partial coding capacity, 
yielding three transcripts of 2,107, 2,197 and 2,228 pb that 
differ only in their 5’-untraslated region (5’-UTR) and all 
encoding the same 532 amino acids (59.7 kDa) Grb7 protein. 
The C-terminal truncated variant Grb7V lacking the SH2 
domain has 447 amino acids (49.4 kDa) and is encoded by a 
1,667 pb transcript expressed by an altered gene with only 
13 exons of which only 12 have total or partial coding capac-
ity [18, 19]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. Chromosomal localization of the human GRB7, GRB10 
and  GRB14 genes. The cartoon represents partial ideograms of 
human chromosomes (Chr) 17, 7 and 2 where the GRB7, GRB10, 
and  GRB14 genes are respectively located. The approximate 
distribution of chromosome bands corresponding to the loci: 17q12-
q21.1 (for GRB7), close to the centromere in the long arm of chro-
mosome 17; 7p11.2-p12 (for GRB10), close to the centromere of 
the small arm of chromosome 7; and 2q22-q24 (for GRB14), in the 
middle part of the long arm of chromosome 2, are shown. See text 
for additional details. 
 Mouse  Grb7 is located in chromosome 11 [14, 20] but in 
rats this gene maps in chromosome 10 [21, 19]. In pig, GRB7 
maps in chromosome 12 [22] and in chimpanzee is located in 
chromosome 17 like in human [19, 21]. The human and 
mouse chromosomal loci where GRB7 reside, are evolution-
arily conserved regarding the order and orientation of the 
genes they contain [20]. Murine Grb7 mRNA is highly ex-
pressed in liver and kidney and to a lesser extent, in testis 62    Current Genomics, 2008, Vol. 9, No. 1  Lucas-Fernández et al. 
and ovary with trace levels in lung, yielding a transcript of 
approximately 2.3 kb [23]. 
  Among the new uncovered functional roles of the Grb7 
protein, it has been recently described that it can act as a 
translational repressor upon binding to the 5’-UTR of a tar-
geted mRNA, thereby blocking the recruitment of the trans-
lation eukaryotic initiation factor 4E (eIF4E) and silencing 
protein expression [8]. 
IMPLICATION OF GRB7 IN CANCER 
 The  GRB7 and ERBB2 genes are co-amplified and/or 
overexpressed in human gastric and esophageal carcinoma 
cell lines, and in primary gastric and esophageal cancers, 
particularly within the lower segment of the esophagus [14, 
15, 24-26]. In some human esophageal carcinoma patients, 
amplification of the GRB7 gene was not detected but its 
mRNA was overexpressed and co-expressed with the ERBB2 
and/or EGFR genes [27, 28]. In contrast, a positive correla-
tion between an increased number of copies of the GRB7 
gene and elevated mRNA expression levels was found in 
gastric cancers [29]. The aforementioned Grb7 truncated 
isoform Grb7V, in which the SH2 domain was substituted by 
a short hydrophobic tail, was detected in highly invasive 
human esophageal carcinomas, presenting a particularly en-
hanced expression in metastasized lymph nodes, underscor-
ing the role of the Grb7 protein in tumor invasion [18]. Ge-
nomic hybridization analysis using cDNA microarrays de-
tected the co-amplification of the ERBB2 and GRB7 genes in 
a series of human gastric cancer xenographs, primary tumors 
and tumor cell lines, although overexpression was apparent 
for ERBB2 but not for GRB7 [25]. 
 Co-amplification  of  ERBB2 and GRB7 was also found in 
human breast cancer cell lines [17], and has been addition-
ally detected in non-invasive ductal carcinomas in situ [16]. 
Increased expression of GRB7 correlates with a lower sur-
vival rate in breast cancer patients with tumors with either 
high or low expression of ERBB2 [30, 31]. A subset of the 
estrogen receptor (ER)-negative breast cancer subtype pre-
sents overexpression of the genes within the ERBB2 ampli-
con including GRB7 [32]. GRB7 expression not only posi-
tively correlates with ERBB2 expression in human breast 
carcinoma but with ERBB3 expression as well [33], although 
the latter maps at chromosome 12q13 [34]. Nevertheless, no 
association was found between common single-nucleotide 
polymorphisms (SNPs) in genes within the ERBB2 amplicon 
and the risk of developing breast cancer in a study conducted 
in over two thousand patients when compared to a similar 
number of control subjects [35]. 
 The  GRB7 gene also co-amplifies with additional genes 
located within the ERBB2 amplicon such as CAB1, A39, C51 
and MLN64 in gastric and breast cancers [17, 24]. However, 
the minimum region of recurrent amplification within the 
17q12 amplicon includes just the STARD3, ERBB2 and 
GRB7 genes in human breast cancer [36]. 
 An  increased  GRB7 gene copy number was also detected 
in human testicular germ cell tumors, exhibiting a particu-
larly high expression in immature teratoma, embryonal car-
cinoma, choriocarcinoma and some (but not all) seminoma, 
in contrast to its rare incidence in normal testicular tissues 
[37, 38]. In fact, GRB7 is approximately 5-fold downregu-
lated in most seminomas as compared to embryonal carci-
nomas [39]. However, no elevated ERBB2 expression was 
found in these testicular tumors [37]. Instead, there is a posi-
tive correlation between the co-expression of GRB7 and KIT 
(a gene encoding the v-kit Hardy-Zuckerman 4 feline sar-
coma viral oncogene homolog receptor, another tyrosine 
kinase receptor that interacts with Grb7 and which maps at 
the locus 4q11-q12) in seminomas, but not in non-seminoma 
testicular tumors. In the latter, however, there was a positive 
correlation between the co-expression of GRB7 and KRAS2, 
a gene encoding a small G protein of the Ras family, which 
maps to the 12p12.1-p11.2 locus [40]. 
  The expression of the GRB7 gene was also increased in 
cells from chronic lymphocytic leukemia patients, in which 
the highest expression levels were found in the advanced 
stages of the disease (stage IV) as compared to less advanced 
stages (stage I) [41]. 
THE GRB10 GENE 
  In human, as in chimpanzee, the GRB10 gene is located 
in chromosome 7 (see Fig. (2) center panel). The DOPA-
decarboxylase (DDC) and Cordon-bleu (COBL) genes flank 
it and maps at the 7p11.2-p12 locus (or as described by oth-
ers at the 7p11.1-p12 or 7p11.2-p12.2 locus), close to any 
event of the EGFR gene, which is located at  3.7 Mb to-
ward the centromere [19, 21, 42-45]. This gene is alterna-
tively spliced yielding transcripts that may encode a protein 
with a partial deletion of the PH domain and/or an N-
terminal sequence addition. High expression of a prominent 
4.7 kb transcript for the human GRB10 splice variant de-
noted GRB10/IR-SV1 (insulin receptor bind spliced variant 
1) (hGrb10), a 548 amino acid (61.9 kDa) protein, with a 
deletion of 80 amino acids in the PH domain and a distinct 
N-terminus addition as compared to the mouse Grb10, are 
found in skeletal muscle and pancreas, and in lesser quanti-
ties in heart, brain, placenta, lung, liver and kidney [46]. A 
second GRB10 5.6 kb transcript encoding a 536 amino acid 
(60.7 kDa) protein with an intact PH domain named GRB-
IR/GRB10 (hGrb10) was later described and its expres-
sion also detected to be elevated in pancreas and skeletal 
muscle although it is also present in most tissues [47]. A 
third isoform of 594 amino acids (67.1 kDa) denoted 
hGrb10, containing the same N-terminal extension as 
hGrb10 but with an intact PH domain, was also described 
[43]. Its expression was also high in skeletal muscle and in 
some tumor cells, as HeLa cells and diverse breast cancer 
cell lines [43]. The detailed cloning and sequence analysis of 
the human GRB10 gene shows the presence of 17 exons (or 
22 if subdivided exons are considered) among translated and 
untranslated ones (see [19]), of which 14 participate in the 
translation of all isoforms described up to day, including not 
only the mentioned hGrb10, hGrb10 and, hGrb10 but 
also the additional described hGrb10, hGrb10 and 
hGrb10 isoforms, while 3 additional exons are translated in 
at least one of the isoforms [48]. 
 The  mouse  Grb10 gene maps to chromosome 11, and is 
also flanked by the Ddc and Cobl genes. Like its human 
ortholog, Grb10 is in the proximity of the Egfr gene, located 
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was initially proposed that mouse Grb10 encodes several 
isoforms of the protein (mGrb10) because of the existence of 
alternative translational start sites [49]. The most abundant 
transcripts are 5.5 kb and 1.5 kb long and the transcription of 
the mGrb10 and mGrb10 isoforms is initiated at exon 1, 
although the mGrb10 isoform originates from a spliced 
variant transcript lacking exon 5 as compared to the full-
length transcript encoding the mGrb10 isoform [50]. The 
start of the translation occurs in exon 3 and ends at exon 18. 
The correlation between Grb10 exons and the protein func-
tional domains is as follows: exon 4 encodes the PR domain, 
exons 10-13 the PH domain, exons 13-16 encode the BPS 
domain and part of the SH2 domain and exons 16-18 the rest 
of the SH2 domain [50]. 
  The expression of two prominent GRB10 transcripts was 
also detected in the adipose tissue of the rhesus monkey [46]. 
Overexpression of Grb10 mRNA occurs in fetal rat liver as 
compared to adult liver, where it nearly disappears, suggest-
ing a role of this gene in tissue growth [51]. This was further 
supported by the enhanced expression of the Grb10 gene 
found in fast growing cultured pre-implantation mouse em-
bryos (blastocytes) [52]. 
IMPRINTING OF THE GRB10 GENE 
  Genetic imprinting consists in the selective expression of 
a single allele of a given gene either that residing in the 
mother or in the father homologous chromosome, what re-
sults in a non-Mendelian inheritance pattern. The mechanism 
of imprinting may underlie the methylation of CpG dinucleo-
tides lying in selected sectors of the gene such as the pro-
moter region, catalyzed by specific DNA methyl-transferases; 
and/or chromatin modification, involving the posttransla-
tional acetylation and/or methylation of histones bound to 
the targeted gene catalyzed by histone acetyl-transferases 
and methyl-transferases, respectively. These processes usu-
ally occur at the gametes and the imprinted mark is thereafter 
transmitted during embryonic development and through the 
subsequent developmental stages up to adulthood. In gen-
eral, these differential DNA and histone modifications result 
in the epigenetic silencing of the targeted genes. 
 The  human  GRB10 gene may be imprinted either pater-
nally or maternally, or expressed from both alleles depend-
ing on the tissue and the protein isoform under consideration. 
Thus, in human fetal brain, the paternal allele is the one tran-
scribed for most of the Grb10 isoforms, while in skeletal 
muscle, the transcribed allele for the Grb101 isoform is 
from maternal origin [48], whereas biallelic expression was 
detected in other fetal peripheral tissues [53]. These and 
other authors noticed that the paternal-specific expression of 
human GRB10 in the fetal central nervous system (brain and 
spinal cord) appositely differs from the maternal allele-only 
transcription in the mouse brain [48, 53]. Despite the im-
printed nature of GRB10, no allele-specific methylation of 
most of the 5’ CpG island of this gene in human fetal brain 
was found by these authors [48] and the silenced mouse 
Grb10 allele remained inactive despite the exposure of cells 
to inhibitors of DNA methylation and of histone deacetylases 
[54]. Additional work revealed the maternal expression of 
Grb10 in mouse embryos, adult kidney and liver; while in 
adult brain the paternal allele was mainly expressed [55]. 
Also, Grb10 is paternally imprinted in bovine embryos, be-
ing expressed in both in vitro-fertilized and parthenogeneti-
cally activated blastocysts [56]. 
  Uniparental disomy (UPD) consists in the inheritance of 
two homologous copies of a given chromosome (or part of a 
chromosome) from a single parent, either the mother or the 
father. This is most likely due to the rescue-driven loss of a 
third copy of the chromosome in an otherwise non-viable 
trisomic zygote, among other mechanisms. As earlier re-
viewed, paternal uniparental disomy (patUPD) affecting the 
mouse Grb10 gene results in embryonic and postnatal over-
growth while maternal uniparental disomy (matUPD) results 
in undergrowth [57]. 
  Within the promoter region of mouse GRB10 are located 
two major 1.4 kb long CpG islands, the first encompassing 
exon 1a and the second encompassing exon 1b [50, 55]. 
These CpG islands are also present at analogous positions in 
human GRB10, presenting notorious sequence homologies in 
both species, except for a 600 bp mouse-specific tandem 
repeat in the promoter region of the parentally expressed 
gene [55, 58]. Both in mouse and human, DNA methylation 
at the GRB10 promoter was not different in the paternal and 
maternal expressed alleles in the first CpG island, which was 
hipomethylated, but increased methylation was found in the 
second CpG island in the maternal allele as compared to the 
paternal one [55, 58]. Most recently, however, a third CpG 
island was identified around the subdivided exon 1c in 
mouse  Grb10 that exhibits extensive methylation in both 
maternal and parental alleles in neurons and glial cells [59]. 
Two distinct promoters, a major one active in most tissues 
and a brain-specific promoter located downstream of the first 
one were thus proposed to exist in the mouse and human 
GRB10 genes [55]. In mouse, methylation of the CpG is-
lands was not only detected during oocyte growth but they 
kept extensively methylated into adulthood [60]. Most inter-
estingly, differential acetylation and methylation of histones 
in the nucleosomes containing the CpG islands 1 and 2 in the 
promoter of the parental alleles of the mouse Grb10 gene 
have been detected in neurons, glia and fibroblasts, what 
may contribute to the epigenetic control of the expression of 
this gene [59]. 
  As a consequence of imprinting, a deviation of a Men-
delian 1:1 female/male transmission ratio of the grandparen-
tal alleles in the paternal chromosome containing the im-
printed gene GRB10 was found in females as compared to 
males where the fraction of the transmitted grandmaternal 
alleles was 0.38 and 0.5 respectively due to uneven loss of 
human embryos in the former [61]. 
IMPLICATION OF GRB10 IN PATHOLOGICAL 
PROCESSES 
  Several connections between Grb10 and cancer have 
been reported. Thus, Grb10 was shown to be overexpressed 
more than three-fold in mouse cells infected with tumori-
genic adenovirus 12 as compared with cells infected with 
non-tumorigenic adenovirus 5 [62]. Also, increased expres-
sion of GRB10 mRNA was detected in primary cervical 
squamous carcinomas in human as compared to normal uter-
ine squamous cell tissues [63]. Furthermore, dysregulation of 64    Current Genomics, 2008, Vol. 9, No. 1  Lucas-Fernández et al. 
GRB10 has been detected in human metastatic malignant 
melanomas [64]. 
  Several transgenic mouse lines with ectopic overexpres-
sion of Grb10 have been shown to present growth retarda-
tion after weaning and hyperinsulinemia due to insulin resis-
tance [65]. Conversely, knockout mice with a disrupted 
Grb10 gene exhibited body overgrowth, particularly due to 
muscle mass increase accompanied by decreased adiposity, 
as well as increased glucose tolerance, insulin sensitivity and 
insulin-mediated cellular signaling [66, 67]. These observa-
tions appear to link Grb10 to the pathogenesis of type 2 dia-
betes. In this context, it has been shown that some SNPs in 
the GRB10 gene correlates indeed with type 2 diabetes in 
human [68]. 
  Albeit the important role of Grb10 in organismal devel-
opment, and in contrast to the RET tyrosine kinase, which is 
one of its upstream signaling receptors, mutations in GRB10 
were not linked to Hirschsprung disease, a congenital condi-
tion characterized by the absence of intrinsic enteric gan-
glion cells in some sectors of the gastrointestinal track, in-
cluding the colon, which results in a distended atonic mega-
colon [69]. 
  The Silver-Russell syndrome (SRS) is an inherited condi-
tion characterized by intrauterine and postnatal growth retar-
dation resulting in typical dysmorphic features, such as a 
small triangular face with down-turned corners of the mouth, 
prominent forehead, skeletal asymmetry of the trunk and 
limbs, and clinodactyly of the fifth finger, which consists in 
its inner bending due to an undeveloped middle phalange 
[70]. Multiple genetic alterations have been associated with 
SRS. Among them and of particular importance to us are: the 
maternal uniparental disomy of chromosome 7 (matUPD7) 
occurring in 7-10 % of SRS patients, in which disruption of 
genomic imprinting takes place; and a few patients where 
maternal duplication of the 7p11.2-p13 region was detected 
[70-72]. Although GRB7 maps close to a translocation 
breakpoint in chromosome 17 detected in three SRS patients, 
the implication of the GRB7 gene in this syndrome was soon 
discarded [73]. 
  The first indication, however, of the possible implication 
of GRB10 as a candidate gene for the SRS was obtained in 
the mouse, where the imprinted gene Meg1/Grb10 was asso-
ciated with the maternal or paternal duplication of proximal 
chromosome 11, where this gene is located, which was cor-
related with prenatal growth retardation or growth promo-
tion, respectively [74]. Soon thereafter, sub-microscopic 
duplication of the 7p12.1-p13 region of human chromosome 
7, which includes the GRB10 gene among others, was de-
tected in mothers and daughters with SRS phenotypes [75, 
76], although this duplication was found in only 2.4 % of 32 
additional SRS patients screened [77]. Interestingly, a partial 
matUPD7 was described in an SRS patient in which only a 
small segment of matUPD7 occurred while the rest of chro-
mosome 7 was of biparental inheritance, including GRB10 
[78]. This particular segmental matUPD7 led to suggest that 
GRB10 may not be central to SRS etiology [71], although 
SRS patients with three GRB10 copies were later detected 
[79]. Also, against the implication of GRB10 in the etiology 
of SRS it has been argued that the imprinting of this gene in  
 
brain and skeletal muscle is incomplete and isoform-specific, 
and that there is absence of GRB10 imprinting in the growth 
cartilage plates, a tissue involved in very active growth in 
young subjects [80]. 
 Also,  mutations  in  GRB10 accounting for a proline to 
serine substitution at residue 95 of Grb10 were detected in 
two out of 58 screened SRS patients [81], although an addi-
tional study did not reveal GRB10 mutations in a subset of 
18 SRS patients with non-matUPD7 [53]. In contrast, al-
though frequent SNPs were found in exons 3 and 12, and 
intron 3, as well as a heterozygous microsatellite repeat in 
intron 14 of the GRB10 gene of SRS patients, no other al-
terations have been detected, further suggesting to those 
authors that this gene does not play a major role in the etiol-
ogy of SRS [48]. Furthermore, no epimutations in the differ-
entially-methylated region of the GRB10 gene were found in 
a large set of 46 screened SRS patients performed in two 
independent studies [58, 82]. 
THE GRB14 GENE 
 Using  fluorescence  in situ hybridization, the GRB14 gene 
was located in the long arm of human chromosome 2, most 
precisely in the 2q22-q24 locus (see Fig. (2) right panel), 
relatively close to the ERBB4 gene located at the 2q33.3-q34 
locus [83]. These authors also detected minor hybridization 
signals at 12q13 and 6q27, which they suggested were de-
rived from other GRB7 related genes [83]. The GRB14 gene 
comprises 14 exons, which yield the 2,382 bp GRB14 tran-
script that encodes for the 540 amino acid residues (60.9 
kDa) protein (see [19, 21]). The human GRB14 mRNA is 
highly expressed in liver, kidney, pancreas, ovary, testis, 
heart and skeletal muscles and it is also very abundantly pre-
sent in kidney embryonic cells, some prostate cancer cell 
lines and breast cancer cells [84], particularly in ER-positive 
cell lines [84, 85]. Originally, three most prominent mRNA 
transcripts of 2.3, 2.4 and 2.5 kb were detected, which were 
frequently accompanied by a less abundant 9.5 kb transcript 
[84].  
  The chimpanzee and mouse GRB14 orthologs are located 
in chromosome 2, whereas the rat gene maps in chromosome 
3 (see [19]). In both mouse and rat, Grb14 is a 538 amino 
acid protein highly expressed in insulin-responsive tissues 
such as liver, heart, skeletal muscle, pancreas and white adi-
pose tissues, as well as in the brain, and is encoded by a ma-
jor 2.5 kb transcript and a lesser 1.9 kb transcript [86]. 
Mouse Grb14 bears 93 % sequence identity to rat Grb14 and 
85 % sequence identity to human Grb14 [87]. 
IMPLICATION OF GRB14 IN PATHOLOGICAL 
PROCESSES 
 The  GRB14 gene is highly transcribed in human breast 
and prostate tumor cells [84, 85], which might underscore its 
potential implication in cancer biology. Moreover, a high 
mutation frequency of this gene has been found in human 
colorectal cancers showing microsatellite instability (30 % of 
primary tumors and 50 % of tumor cell lines), as they are 
prone to failure in repairing errors occurring during DNA 
replication [88]. GRB14 expression is under hormonal con-
trol since it is downregulated by estradiol and upregulated by  
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insulin [85], and overexpression of GRB14 has been detected 
in animal models and human patients exhibiting insulin re-
sistance due to type 2 diabetes [89]. 
FUTURE PERSPECTIVES 
  The study of the organization and control of the genes 
encoding the three Grb7 family members is still in its in-
fancy. Among the relevant issues that still require great ex-
perimental attention we should mention the full characteriza-
tion of the promoter regions of GRB7, GRB10, and GRB14, 
the complete identification of the panel of transcription fac-
tors and accessory proteins involved in their expression and 
the potential role of iRNAs controlling the translation of 
their respective transcriptional products. Among the specific 
issues related to the alterations observed in the organization 
of these genes, it should be of interest to unravel the underly-
ing mechanisms of amplicon duplication involving the GRB7 
and ERBB2 genes, as observed in some human cancers (see 
[1-3, 7] for reviews and references therein); as well as the 
mechanisms responsible for the observed segmental UPD of 
chromosome 7 in a number of Silver-Russell syndrome pa-
tients that, although appears not to affect the GRB10 gene 
[78], might clarify the basis of this congenital defect. Given 
the negative control exerted by the Grb10 and Grb14 pro-
teins on cell proliferation (see [1-4, 9-11, 13] for reviews and 
references therein), it should be of interest to perform a sys-
tematic screening of tumors in search of disabling mutations 
affecting the GRB10 and GRB14 genes, in order to determine 
whether they might work as tumor suppressor genes. Alter-
natively, and given that Grb10 also appears to exert a pro-
mitogenic function in some context [12], it should be of in-
terest to explore whether mutations in the GRB10 gene, in 
addition to those already known, could be of relevance to 
explain the high proliferation rate of some tumors. 
Poly(ADP-ribose) polymerases catalyze the poly-ADP-
ribosylation of proteins, including those involved in the con-
trol of the maintenance of genomic functionality and integ-
rity, because of their participation in single- and double-
strand DNA repair, recombination and replication, gene tran-
scription and control of telomeric functions [90]. Tankyrase-
2, which belongs to this group of poly(ADP-ribose) polym-
erases, has been shown to bind to the Grb14 protein [91]. As 
this enzyme has a relevance in telomere maintenance [90], 
further work should be performed to determine whether or 
not the GRB14 gene might control processes related to cellu-
lar senescence. Finally, given the variety of signaling path-
ways in which the three family members Grb7/Grb10/Grb14 
appear to be involved, it may not be out of the ordinary that 
mutations and/or rearrangements affecting their encoding 
genes, and hence the stability of their transcripts and/or the 
functionality of their protein products, are found in addi-
tional congenital pathological processes in human and/or 
animal models, and hence clarifying their etiologies. A pre-
diction that only a sustained experimental effort in this direc-
tion may only confirm this or contrarily falsify. 
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ABBREVIATIONS 
Akt =  v-akt murine thymoma viral oncogene  
homolog 
BPS  =  Between PH and SH2 
COBL =  Cordon-bleu gene 
DDC =  DOPA-decarboxylase gene 
EGFR  =  Epidermal growth factor receptor 
eIF4E  =  Eukaryotic initiation factor 4E 
Eph  =  Erythropoietin-producing hepatocellular  
carcinoma cells 
ER =  Estrogen  receptor 
ERBB  =  Erythroblastic leukemia viral oncogene  
homolog 
FAK  =  Focal adhesion kinase 
Grb  =  Growth factor receptor bound 
IGF-I  =  Insulin-like growth factor-I 
IR =  Insulin  receptor 
KIT =  v-kit Hardy-Zuckerman 4 feline sarcoma 
viral oncogene homolog 
matUPD =  Maternal  UPD 
matUPD7  =  matUPD of chromosome 7 
PDGF-BB  =  Platelet-derived growth factor-BB 
patUPD =  Paternal  UPD 
PH =  Pleckstrin  homology 
PI3K =  Phosphatidylinositol  3-kinase 
PR =  Proline-rich 
RA =  Ras-associating 
SH2  =  Src homology 2 
SH3  =  Src homology 3 
SNP =  Single-nucleotide  polymorphism 
UPD =  Uniparental  disomy 
5’-UTR =  5’-untraslated  region 
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